ReviewApplied microbiology and biotechnology2026
Biofilm state transitions: quorum sensing inhibition and network destabilization.
Review in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biofilms are traditionally viewed as surface-associated, extracellular polymeric substance (EPS)-encased aggregates. Here, we present a theoretical perspective positioning biofilm formation as a coordinated regulatory state transition, drawing on a synthesis of published transcriptomic, proteomic, and metabolic studies that document systemic reprogramming of gene regulatory networks, second-messenger signaling (e.g., cyclic di-GMP), quorum sensing circuits, and metabolic flux distribution. Spatial stratification within biofilms generates metabolically distinct subpopulations-including persisters and dormant cells-that enhance collective robustness. Using Salmonella enterica serovar Typhimurium as a model organism, we formalize quorum sensing inhibition (QSI) as one plausible bifurcation control parameter, with its destabilizing effects described by a coarse-grained phenomenological model governed by cooperativity, population density, and signal decay rates. We show, through bifurcation analysis and cross-referencing with published experimental biofilm disruption studies, that sufficiently strong signal-decay-type QSI can collapse the high-signal biofilm attractor without imposing strong bactericidal pressure. This network-centric perspective elucidates how destabilization of collective regulatory circuits-rather than direct cell killing-can enhance therapeutic susceptibility. Additionally, the framework provides a conceptual basis for combinatorial strategies integrating antivirulence interventions with conventional antimicrobials, with the potential to reduce the pace of resistance evolution by targeting cooperative rather than essential traits. Predictions arising from this framework require direct experimental validation to establish quantitative accuracy. KEY POINTS: • Biofilms can be conceptualized as coordinated regulatory attractor states sustained by multilayered feedback coupling. • QSI is formalized as one plausible bifurcation control parameter capable of destabilizing the high-commitment biofilm state when implemented as signal-degradation-type inhibition. • Network destabilization may enhance antimicrobial susceptibility while imposing lower evolutionary pressure than direct bactericidal approaches.
Indexed as
Identifiers
42878875What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.